Show source-provided references
1. Molecular modeling study and synthesis of novel pyrrolo[2,3-d]pyrimidines and pyrrolotriazolopyrimidines of expected antitumor and radioprotective activities
10.1016/j.bmc.2007.11.072 ↗2. Synthesis of Non-nucleoside Analogs of Toyocamycin, Sangivamycin, and Thiosangivamycin: Influence of Various 7-Substituents on Antiviral Activity
10.1021/jm950444j ↗3. Pyrrolo [2,3-d] pyrimidines and Pyrido [2,3-d] pyrimidines as Conformationally Restricted Analogues of the Antibacterial Agent Trimethoprim
10.1016/0968-0896(96)00045-4 ↗5. Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity
10.1016/j.bmcl.2008.11.077 ↗6. Synthesis, analgesic and anti-inflammatory activities evaluation of some bi-, tri- and tetracyclic condensed pyrimidines
10.1016/j.ejmech.2009.06.028 ↗8. Coordination Possibility of Uracil and Applications of Some of Its Complexes: A Review
9. Effect of Cd, Zn and Hg complexes of barbituric acid and thiouracil on rat brain monoamine oxidase-B (in vitro)
10.1016/j.cbi.2013.11.012 ↗10. Synthesis, characterization and antimicrobial activities of some 5-bromouracil–metal ion complexes
10.4314/bcse.v33i2.6 ↗13. Ruthenium(II) complexes with 6-methyl-2-thiouracil selectively reduce cell proliferation, cause DNA double-strand break and trigger caspase-mediated apoptosis through JNK/p38 pathways in human acute promyelocytic leukemia cells
10.1038/s41598-019-47914-x ↗14. Synthesis and Structural Characterization of New Cu(I) Complexes with the Antithyroid Drug 6-n-Propyl-thiouracil. Study of the Cu(I)-Catalyzed Intermolecular Cycloaddition of Iodonium Ylides toward Benzo[b]furans with Pharmaceutical Implementations
10.1021/ic3014255 ↗15. Elaborated studies for the ligitional behavior of thiouracil derivative towards Ni(II), Pd(II), Pt(IV), Cu(II) and UO22 2 ions
10.1016/j.saa.2012.05.017 ↗18. Synthesis, characterization and anticancer activity of new zinc(II), molybdate(II), palladium(II), silver(I), rhodium(III), ruthenium(II) and platinum(II) complexes of 5,6-diamino-4-hydroxy2-mercaptopyrimidine
10.1016/j.ica.2014.07.031 ↗19. Mixed ligand complexes of Cu (II)/Ni (II)/Zn (II) ions with 5-Fluorouracil (5-FU) in the presence of some amino acid moieties: Structural and antimicrobial studies
20. A new antimetabolite, 5-morpholinomethyl-2-thiouracil—Spectral properties, thermal profiles, antibacterial, antifungal and antitumour studies of some of its metal chelates
10.1039/b202127g ↗21. A series of Nano-sized metal ion–thiouracil complexes, tem, spectral, γ-irradiation, molecular modeling and biological studies
10.13005/ojc/310406 ↗22. Synthesis, characterization and antitumour activity of metal complexes of 5-carboxy-2-thiouraci
10.1155/MBD.1998.35 ↗24. Hoeschele, J.D., and Piscataway, N.J. (1980). Ethylenediamineplatinum(II) 2,4-Dioxopyrimidine Complexes. (4 207 416), U.S. Patent.
26. Synthesis, characterization and antiproliferative behavior of tricarbonyl complexes of rhenium(I) with some 6-amino-5-nitrosouracil derivatives: Crystal structure of fac-[ReCl(CO)3(DANU-N5,O4)] (DANU = 6-amino-1,3-dimethyl-5-nitrosouracil)
10.1016/j.jinorgbio.2005.05.003 ↗27. Synthesis and crystal structures of tetra- and hexanuclear copper(I) complexes of pyrimidine derivatives, [Cu4(C4H8N2S4)](ClO4)4 and [Cu6(C5H5N2S)6]
10.1016/S0020-1693(00)84961-0 ↗28. Synthesis, characterization and in vitro cytotoxicity of homobimetallic complexes of palladium(II) with 2-thiouracil ligands. Crystal structure of [Pd2(TU)(PPh3)3Cl2]
10.1002/aoc.1227 ↗29. Supramolecular architectures based on p-cymene/ruthenium complexes functionalized with nucleobases
10.1039/C7CE01496A ↗30. Synthesis, structural characterization and biological studies of the triphenyltin(IV) complex with 2-thiobarbituric acid
10.1016/j.ejmech.2011.04.005 ↗31. Crystal structure and properties of the precursor [Ni(H2O)6](HTBA)2.2H2O and the complexes M(HTBA)2(H2O)2 (M = Ni, Co, Fe)
10.1016/j.poly.2013.12.021 ↗34. Cobalt(III) promoted ligand fusion reactions of thiobarbituric acid and 4,6-diamino-2-thiouracil (or 4-amino-2-thiouracil)
10.1016/S0020-1693(02)00696-5 ↗35. Reactions of an Osmium-Hexahydride Complex with Cytosine, Deoxycytidine, and Cytidine: The Importance of the Minor Tautomers
10.1021/ic3013238 ↗37. Dinuclear bis(bipyridine)ruthenium(II) complexes [(bpy)2RuII{L}2−RuII(bpy)2]2+ incorporating thiouracil-based dianionic asymmetric bridging ligands: Synthesis, structure, redox and spectroelectrochemical properties
10.1039/b201468h ↗39. Ahmed, N.M., Lotfallah, A.H., Gaballah, M.S., Awad, S.M., and Soltan, M.K. (2023). Novel 2-Thiouracil-5-Sulfonamide Derivatives: Design, Synthesis, Molecular Docking, and Biological Evaluation as Antioxidants with 15-LOX Inhibition. Molecules, 28.
10.3390/molecules28041925 ↗40. New Cu(II), Pd(II) and Au(III) complexes with 2-thiouracil: Synthesis, Characteration and Antibacterial Studies
10.1134/S1070363222080278 ↗41. Synthesis, antimicrobial potential and computational studies of crystalline 4-bromo-2-(1,4,5-triphenyl-1H-imidazole-2-yl)phenol and its metal com-plexes
10.1039/D2CE01118B ↗42. Synthesis, antioxidant activity, anti-microbial efficacy and molecular docking studies of 4-chloro-2-(1-(4-methoxyphenyl)-4,5-diphenyl-1H-imidazol-2-yl)phenol and its tran-sition metal complexes
10.1039/D2RA08327B ↗43. New heteroleptic palladium(II) dithiocarbamates: Synthesis, characterization, packing and anticancer activity against five different cancer cell lines
10.1002/aoc.3445 ↗44. Synthesis, spectroscopic characterization studies of chelating complexes and their applications as antimicrobial agents, DNA binding, molecular docking, and electrochemical studies